Combining the Power of PASV with CT Rated Ports

Xcela* Plus Power-Injectable Portsare indicated up to 5mL/sec and 300 psi and are MRI-conditional—3 Tesla.

Plastic PortNon-Valved

Plastic Port withPASV Valve Technology

Titanium Port withPASV Valve Technology

Radiopaque under fluoroscopy

PASV Valve Technology designed to resist backflow, maintain patency, and provides a saline-only flushing option†

Flexible, kink-resistant catheter material

1/2” Septum diameterfor ease of port access

†Follow institution protocol

Multiple options designed to accommodate patient anatomy and clinical needs.[ [

PASV Valve Technology is Designed to:

The Power of PASVThe PASV* Valve Technology design automatically resists backflow,

reducing blood reflux that could lead to catheter-related complications.

Open for sampling and automatically close to resist pressure fluctuations that may cause blood reflux

Remain closed during normal increases in central venous pressure to prevent blood reflux in the catheter tip

Open with minimal pressure and automatically close after infusion

Reduced Complications†

(associated with catheter occlusion)Decreased Costs††

†Carlo JT, Lamont JP, McCarty TM, Livingston S, Kuhn JA. A Prospective Randomized Trial Demonstrating Valved Implantable Ports Have Fewer Complications and Lower Overall Cost than Non-valved Implantable Ports. Am J Surg 2004;188:722-727. (Clinical data based on Vaxcel with PASV Port, a predicate to the Xcela Plus Port with PASV Valve Technology.)

†† Failure to achieve blood draw: non-valved=$480, valved=$303; $177 net savings per port. General maintenance costs: non-valved=$195, valved=$109; $86 net savings per port.Cost information based on Data from 2004.

39%reductionnet maintenance cost per port

Non-Valved Ports PASV Valve Technology Ports

n=73

6.7%

4.4%

10

5

0RATE

OF

OCC

LUSI

ON

(%)

n=73

1,545

750

0

1,000

2,000

NU

RSIN

G T

IME

(MIN

)

15

7

11%

n=73

5.8%

0INAB

ILIT

Y TO

DRA

W B

LOO

D (%

)

1,000

800

600

400

200

$675

n=73

$412

0TOTA

L CO

ST P

ER P

ATIE

NT

($)

Infusion Aspiration Closed

47% reduction in inadequate blood draws

51% reduction in troubleshooting time for nurses

35% reduction in tPA usage

PA S V

T

E C H N O L O G

Y

VA LVE

USA > 14 Plaza Drive, Latham, NY 12110 > tel: 800-772-6446 > fax: 518-798-1360 > Canada tel: 800-268-0184International > Haaksbergweg 75 (Margriettoren), 1101 BR, Amsterdam Z-O > The Netherlandstel: +31 (0)20 753 2949 > fax: +31 (0)20 753 2939

www.angiodynamics.com

*AngioDynamics, the AngioDynamics logo, Xcela, LifeGuard, PASV and Navilyst Medical are trademarks and/or registered trademarks of AngioDynamics, Inc., an affiliate or a subsidiary.

Manufacturer: Navilyst Medical, Inc., 26 Forest Street, Marlborough, MA 01752

XCELA PLUS POWER INJECTABLE PORTS

INTENDED USE/INDICATIONS FOR USE: The Xcela Plus Power Injectable Port is indicated for patient therapies requiring repeated access to the vascular system. The port system can be used for infusion of medications, IV fluids, parenteral nutrition solutions, blood products and for the withdrawal of blood samples.

When used with a power injectable needle, the Xcela Plus Power Injectable Port is indicated for power injection of contrast media. For power injection of

contrast media, the maximum recommended infusion rate is 5 mL/sec with a 19 G or 20 G non-coring power injectable needle or 2 mL/sec with a 22 G non-coring power injectable needle.

CONTRAINDICATIONS: Inadequate body size to support device, bacteraemia, sepsis, known or suspected allergic response to materials, infection, peritonitis, past irradiation of prospective insertion site, previous episodes of venous thrombosis or vascular surgical procedures at the postoperative placement site, local

tissue factors will prevent proper device stabilization and/or access.

Refer to package insert provided with the product for complete Instructions for Use, Contraindications, Possible Complications, Warnings and Precautions prior to using this product.

CAUTION: Federal Law (USA) restricts this device for sale by or on the order of a physician.

Xcela Plus Power Injectable Ports

IMPORTANT RISK INFORMATION

Compatibility Options

Xcela Plus Power Injectable Ports are part of a complete portfolio of vascular access products, and are fully compatible with the LifeGuard* Safety Infusion Set.

Easily Identify Critical Information

• Radiopaque “CT” lettering confirms if port is power injectable or flipped

• Patient reminder band, ID card, key tag and record sticker provide added verification that the port is power injectable

© 2015 AngioDynamics, Inc. NAVB 440 NA Rev 3 08/15

Titanium Xcela Plus Port with PASV Valve Technology

Plastic Xcela Plus Port Non-Valved

UPN LumenCath Size

Suture Holes

Valved or Non-Valved

H965440290 Single 6F Non-Filled Non-Valved

H965440300 Single 6F Filled Non-Valved

H965440310 Single 8F Non-Filled Non-Valved

H965440320 Single 8F Filled Non-Valved

H965440370 Single 6F Non-Filled Valved

H965440380 Single 6F Filled Valved

H965440390 Single 8F Non-Filled Valved

H965440400 Single 8F Filled Valved

UPN LumenCath Size

Suture Holes

Valved or Non-Valved

H965440410 Single 6F Non-Filled Valved

H965440430 Single 8F Non-Filled Valved

Plastic Ports

Titanium Ports

XCELA PLUS PORT KITS INCLUDES: Port; Attachable catheter; Snaplocks (1); 18G Introducer needle; 0.038x 50cm J-guidewire; Valved introducer sheath; Metal tunneler; 17G Blunt needle; 22G Huber Needles: Straight (1), 90° (1); 12 mL Syringes: Slip (1), Luer (1); DFU & Patient Packet